CBDNewsAudio

TuesdayOct 02, 2018 8:30 am

CBDNewsAudio – Youngevity International, Inc. (NASDAQ: YGYI) Utilizes Market Experience to Enter CBD Supplement Market

Related Editorial With Canada legalizing cannabis nationwide in October and the 2018 U.S. Farm Bill completely removing hemp from the DEA’s controlled substances list, the stage has been set for an explosion of products ranging from functional foods and supplements to CBD-based (cannabidiol) biopharma indications. U.S. farm bill legalizing hemp could make CBD an open-pit gold mine. List of demonstrable CBD health benefits growing daily. CBD growth may outpace entire cannabis market combined. Even before the landmark inclusion of the Hemp Farming Act of 2018 in this year’s Farm Bill, plant-based nutrition experts at leading omni-direct lifestyle company Youngevity International,…

Continue Reading

ThursdaySep 27, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Eyes New Market Opportunity as Cannabis Use Rises Among Older Generations

Related Editorial Since they came onto the scene after World War II, baby boomers have heavily impacted the world around them, and their influence is being felt now in the emerging cannabis market. A recent survey has shown a significant increase in cannabinoid-derived product consumption in the United States, most notably among baby boomers. With a combination of disposable income, health issues and liberal attitudes towards drugs, baby boomers represent a natural market for cannabis companies. This trend also signifies wider growth and diversification of products and customers in the industry. Marijuana Company of America, Inc. (OTC: MCOA) (MCOA Profile)…

Continue Reading

ThursdaySep 27, 2018 8:30 am

CBDNewsAudio – Sugarmade, Inc. (SGMD) Taps Global Hydroponic Market

Related Editorial The North American cannabis market continues to accelerate as Canada rockets towards the October 17 deadline for the nationwide legalization of recreational marijuana. Hydroponic market trying to keep up with booming cannabis market set to exceed $25 billion by 2021. Continued expansion of cannabis cultivation and demand for controllable production parameters are a boon to hydroponics industry. Healthcare sector increasing demand for CBD from sources such as industrial hemp. Regulatory reform throughout North America and Europe driving change in overall space. The milestone legislation appears set to open the door wider for companies pursuing a position in the…

Continue Reading

FridaySep 21, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Prepares for Upcoming Legalization of Cannabis in Canada

Related Editorial The legalization of cannabis in Canada is about to bring big changes not just for medical cannabis companies but for hemp growers as well. The law legalizing recreational cannabis in Canada will come into force on October 17. This will create new opportunities for hemp growers to produce the plant for CBD extraction. Hemp growers will now be able to profit from all parts of the plant. Cannabis companies are experimenting with growing techniques, expanding their businesses, and seeking supply agreements in preparation for the change. Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile), which grows industrial…

Continue Reading

TuesdaySep 18, 2018 8:30 am

CBDNewsAudio – Earth Science Tech, Inc. (ETST) at the Vanguard of the Cannabinoid Therapeutics Surge

Related Editorial Leveraging ever-expanding scientific evidence of the therapeutic efficacy of CBD (cannabidiol), specialty biotechnology companies are creating novel new formulations of the chemical compound to capitalize on the titanic growth expected in the cannabis-derived pharmaceutical and nutraceutical markets. Global medical marijuana market expected to exceed $55 billion by 2025 Global nutraceuticals market projected to surpass $319 billion by 2023 CBD pharmaceutical and nutraceutical companies poised to reap huge rewards Diverse CBD product lines provide competitive advantages Cannabinoids have been used for medicinal purposes for millennia, but it wasn’t until the discovery of the human endocannabinoid system in the 1990s…

Continue Reading

FridaySep 14, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Likely to Benefit as Farm Bill Deadline Approaches

Related Editorial After years of wrangling, the U.S. Congress stands on the verge of legalizing the cultivation of industrial hemp. Hemp is a variety of the cannabis sativa plant that doesn’t generate a psychoactive effect. Traditionally used to produce cloth and rope, hemp can also now be used in wellness products and food. Competing legislations by the House and Senate are being aligned with an anticipated September 30 deadline. The legalization of hemp has cross-party support and appears likely to pass. The expected change in U.S. law will be beneficial for companies such as Marijuana Company of America, Inc. (OTC:…

Continue Reading

ThursdaySep 13, 2018 8:30 am

CBDNewsAudio – Youngevity International, Inc. (NASDAQ: YGYI) Exploits Growing Popularity of Cannabidiol

Related Editorial Cannabis companies are seeing substantial growth, with the popularity of cannabidiol (CBD) playing a significant part in their positive outlook. CBD is an active ingredient in cannabis. It can provide health benefits without the psychotropic effects of other cannabis chemicals. This has led to a growth in companies selling CBD treatments, sometimes alongside more conventional wellness products. Youngevity International, Inc. (NASDAQ: YGYI) (YGYI Profile) is one of these companies, having recently expanded its range of products to include CBD therapies for muscle pain, sleeplessness and mood improvement. GW Pharmaceuticals Plc (NASDAQ: GWPH) has created a CBD treatment for…

Continue Reading

FridayAug 31, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Making the Most of Approaching Changes in the Cannabis Sector

Related Editorial The pending legalization of recreational cannabis and the extraction of cannabinoids from hemp in Canada is only one in a series of changes bringing expectations of new growth to these industries. Legalization of recreational cannabis in Canada is set to establish an industry worth billions of dollars every year. American companies can make the most of this change through cross-border partnerships and Canadian subsidiaries. Industrial hemp offers another option for companies in this sector, producing and extracting cannabinoids, including CBD and other cannabinoids, from the flowers and leaves will become legal on October 17, 2018. Marijuana Company of…

Continue Reading

FridayAug 24, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Poised to Benefit by Potential Changes in Hemp Legislation

Related Editorial The hemp industry is growing in North America and appears to be set for further expansion thanks to legislation making its way through the U.S. Senate. Hemp is a cultivar of the cannabis sativa plant that lacks the active drug ingredient that makes marijuana users high. It can be used to produce medicinal CBD oil as well as fibers for rope, paper and canvas. Even in difficult growing conditions, hemp can provide higher profits than many other crops. It has a lower environmental impact thanks to low water consumption and little need for chemical fertilizers or pesticides. Marijuana…

Continue Reading

FridayAug 10, 2018 8:30 am

CBDNewsAudio – Marijuana Company of America Inc. (MCOA) Determined to Secure its Share of the Growing Global Hemp Market

Related Editorial In a landmark announcement, the U.S. Food and Drug Administration (FDA) recently approved a drug derived from pure cannabidiol (CBD), Epidiolex, to treat seizures associated with certain forms of severe epilepsy, setting the stage for huge changes in the world of cannabidiol (CBD). FDA approval of a cannabis-based drug represents seismic political, legal and economic shifts Approval likely will lead to more clinical research and further validation of CBD therapeutic efficacy CBD market projected to explode to more than $2 billion in two years with 39 percent CAGR What’s most transformative about this drug approval is that this…

Continue Reading